Patents Assigned to Glycotype GmbH
  • Patent number: 9345794
    Abstract: The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: May 24, 2016
    Assignee: Glycotype GmbH
    Inventors: Steffen Goletz, Antje Danielczyk, Uwe Karsten, Peter Ravn, Renate Stahn, Peter Astrup Christensen
  • Patent number: 7595192
    Abstract: The present invention relates to a process for the production of an immunogenic compound comprising inducing necrosis by temperature in tumor cells and lysing said necrotic tumor cells so as to obtain a lysate. Furthermore, the invention provides a method for the production of a pharmaceutical composition. Additionally, the invention relates to a pharmaceutical composition comprising a lysate obtainable by the aforementioned process. Moreover, methods and uses for vaccination against cancers, tumorous diseases, infections and/or autoimmune diseases comprising administering the cell lysates of the invention or dendritic cells loaded with the cell lysate loaded to an individual are provided.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: September 29, 2009
    Assignee: Glycotype GmbH
    Inventors: Steffen Goletz, Hans Baumeister, Ute Schöber